Výsledky vyhledávání

Akademický článek

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort studyResearch in context

Autor: C. Mirjolet, J.L. Merlin, G. Truc, G. Noël, J. Thariat, J. Domont, P. Sargos, S. Renard-Oldrini, I. Ray-Coquard, X. Liem, C. Chevreau, J.L. Lagrange, M.A. Mahé, F. Collin, F. Bonnetain, A. Bertaut, P. Maingon

Publikováno v: EBioMedicine, Vol 41, Iss , Pp 420-426 (2019)

Purpose: Radiation-induced sarcoma (RIS) is a rare but serious event. Its occurrence has been discussed during the implementation of new radiation techniques and justified appropriate radioprotection requirements. New approaches targeting intrinsic r

Externí odkaz: https://doaj.org/article/cbeb70f179f94a86b875553b8377d7ec

Zobrazit plný text záznamu

Predictive Value of Health-Related Quality of Life on Radiotherapy Related Toxicities in Patients with Head and Neck Cancer

Autor: O. Billa, F. Bonnetain, J. Chamois, A. Ligey, V. Ganansia, S. Renard, M. Quivrin, P. Truntzer, N. Vulquin, G. Noel, P. Maingon, S.T. Dabakuyo-Yonli

Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 112:e62

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::38a93b684c12eec2dd0727bc67505e16
https://doi.org/10.1016/j.ijrobp.2021.12.142

Zobrazit plný text záznamu

Les patients atteints d’un cancer de la tête et du cou

Autor: G. Noel, P. Maingon, M. Quivrin, S. Dabakuyo, M. Vulquin, Oumar Billa, P. Truntzer, F. Bonnetain

Publikováno v: Revue d'Épidémiologie et de Santé Publique. 69:S56-S57

Introduction Au cours de ces dernieres annees, l’evaluation de la qualite de vie liee a la sante est devenue un objectif majeur dans la prise en charge des patients en cancerologie. La qualite de vie comme facteur pronostique a ete etudiee dans plu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::339e53e37c2cc3832a532746ee45c797
https://doi.org/10.1016/j.respe.2021.04.093

Zobrazit plný text záznamu

Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy

Autor: Claire Gallois, Pierre Laurent-Puig, Dewi Vernerey, Edouard Auclin, Julien Taieb, F. Bonnetain, Richard Douard, Aziz Zaanan

Publikováno v: Annals of Oncology. 28:958-968

Since the MOSAIC study, oxaliplatin-based adjuvant chemotherapy has been the standard treatment of stage III colon cancer. Combination therapy with fluoropyrimidines and oxaliplatin has improved overall survival (OS) and reduced the risk of recurrenc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b2bcbc6e77cc25cf3f724f9cd891c5f
https://doi.org/10.1093/annonc/mdx030

Zobrazit plný text záznamu

Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review

Autor: E, Charton, B, Cuer, F, Cottone, F, Efficace, C, Touraine, Z, Hamidou, F, Fiteni, F, Bonnetain, M-C, Woronoff-Lemsi, C, Bascoul-Mollevi, A, Anota

Publikováno v: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 29(4)

The time to deterioration (TTD) approach has been proposed as a modality of longitudinal analysis of patient-reported outcomes (PROs) in cancer randomized clinical trials (RCTs). The objective of this study was to perform a systematic review of how t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::156ff11b19299643e88fccb3b10f790e
https://pubmed.ncbi.nlm.nih.gov/31776827

Zobrazit plný text záznamu

Additional file 1: of PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled study

SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documents. (PDF 82 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::710bcecb0ada94687bcd8191217990f7

Zobrazit plný text záznamu

Additional file 3: of PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled study

Ethical approval document from the Committee for Personal Protection. (PDF 39 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3be762eb6573d016fcd204523699ac47

Zobrazit plný text záznamu

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study

Autor: S. Renard-Oldrini, Georges Noël, Jean-Léon Lagrange, Paul Sargos, Marc-André Mahé, Julien Domont, F. Bonnetain, C. Chevreau, F. Collin, Isabelle Ray-Coquard, J. Thariat, Gilles Truc, Aurélie Bertaut, Jean-Louis Merlin, X. Liem, Céline Mirjolet, Philippe Maingon

Publikováno v: EBioMedicine
EBioMedicine, 2019, 41, pp.420-426. ⟨10.1016/j.ebiom.2019.02.031⟩
EBioMedicine, Elsevier, 2019, 41, pp.420-426. ⟨10.1016/j.ebiom.2019.02.031⟩

International audience; Purpose: Radiation-induced sarcoma (RIS) is a rare but serious event. Its occurrence has been discussed during the implementation of new radiation techniques and justified appropriate radioprotection requirements. New approach

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a37b6e0a2d6d584347daf3088e692a9
https://hal.sorbonne-universite.fr/hal-02110945/document

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání